New Study Highlights Early Warning Signs That Could Help Prevent Sudden Arrhythmic Death in Young People
A recent study unveiled at the ESC Preventive Cardiology 2025 conference indicates that identifying symptoms preceding sudden arrhythmic death syndrome (SADS) may contribute to the preservation of young lives. Researchers indicate that implementing straightforward measures such as early screening and increasing awareness of warning signs could potentially decrease fatalities associated with this concealed and perilous condition.
SADS ranks among the leading causes of sudden cardiac death in young individuals, particularly athletes, yet it continues to be insufficiently studied. The research examined previous cases to gain insights into the condition and explore potential prevention strategies, and it was conducted by Dr Matilda Frisk Torell from the Sahlgrenska Academy at the University of Gothenburg, Sweden.
The researchers examined data from the SUDDY cohort, which includes all 903 cases of sudden cardiac deaths in Sweden among individuals aged 1 to 36 years from 2000 to 2010. In each instance, five individuals of comparable age and gender were chosen as control subjects for the purpose of comparison. The team analysed death certificates, autopsy reports, ECGs, medical histories, and data provided by parents.
Research indicated that SADS accounted for 22% of all sudden cardiac deaths. The majority of individuals impacted were young men, with a median age of 23 years. A significant proportion of individuals had sought medical attention in the six months leading up to their death, with 33% of SADS cases visiting a hospital or doctor compared to 24% of those in the control group. Several indicators were evident.
Dr. Torell stated, “With enhanced awareness of the signs and symptoms that may indicate SADS, including syncope, seizure-like episodes, and pre-excitation, it may be possible to identify at-risk young individuals during healthcare visits.”
Several symptoms were notable. Fainting spells (syncope) occurred in 4.2% of individuals who died from SADS, in contrast to 0.41% of those who did not experience this condition. Hospital visits for seizure-like episodes were significantly more prevalent among SADS cases, recorded at 3.5%, in contrast to the 0.14% observed in control groups. Approximately 20% of individuals exhibited an abnormal ECG, while 11% had previously received a diagnosis of a heart rhythm disorder.
Fifty percent of the deceased exhibited symptoms prior to their deaths, with prevalent indicators including palpitations, fainting, nausea, and signs of infections. The research identified correlations between psychiatric conditions and SADS. Approximately 17% of individuals had received mental health diagnoses, while 11% were on psychiatric medication.
Dr. Torell stated, “This research indicates that there are additional measures we can take to identify the signs of SADS before it becomes critical.” It is recommended that young individuals, particularly those involved in athletics, undergo more comprehensive screening procedures. Preparticipation screenings represent a significant opportunity; however, the current levels of screening are notably low.
In South Asia, the increasing involvement of youth in sports alongside the disparities in healthcare access highlights the significance of this research. Screening for heart conditions among school and college athletes remains infrequent. Furthermore, symptoms such as fainting or nausea are frequently overlooked or inaccurately diagnosed. The findings recommend that public health authorities and policymakers in South Asia implement straightforward ECG screenings, enhance awareness among primary healthcare providers, and incorporate heart health education into sport programs. Preventing SADS does not necessitate expensive tools; it demands careful attention, heightened awareness, and decisive action.